|
1.
|
Froguel P, Zouali H, Vionnet N, Velho G,
Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, et al:
Familial hyperglycemia due to mutations in glucokinase. Definition
of a subtype of diabetes mellitus. N Engl J Med. 328:697–702. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Defronzo RA: Banting Lecture. From the
triumvirate to the ominous octet: a new paradigm for the treatment
of type 2 diabetes mellitus. Diabetes. 58:773–795. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Stumvoll M, Goldstein BJ and van Haeften
TW: Type 2 diabetes: principles of pathogenesis and therapy.
Lancet. 365:1333–1346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Kahn SE, Hull RL and Utzschneider KM:
Mechanisms linking obesity to insulin resistance and type 2
diabetes. Nature. 444:840–846. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Green A, Christian Hirsch N and Pramming
SK: The changing world demography of type 2 diabetes. Diabetes
Metab Res Rev. 19:3–7. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Norris SL, Zhang X, Avenell A, Gregg E,
Brown TJ, Schmid CH and Lau J: Long-term non-pharmacologic weight
loss interventions for adults with type 2 diabetes. Cochrane
Database Syst Rev. 2:CD0040952005.PubMed/NCBI
|
|
7.
|
Ripsin CM, Kang H and Urban RJ: Management
of blood glucose in type 2 diabetes mellitus. Am Fam Physician.
79:29–36. 2009.PubMed/NCBI
|
|
8.
|
Edelman SV, Bode BW, Bailey TS, Kipnes MS,
Brunelle R, Chen X and Frias JP: Insulin pump therapy in patients
with type 2 diabetes safely improved glycemic control using a
simple insulin dosing regimen. Diabetes Technol Ther. 12:627–633.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Nathan DM, Buse JB, Davidson MB,
Ferrannini E, Holman RR, Sherwin R and Zinman B: Management of
hyperglycemia in type 2 diabetes: a consensus algorithm for the
initiation and adjustment of therapy: update regarding
thiazolidinediones: a consensus statement from the American
Diabetes Association and the European Association for the Study of
Diabetes. Diabetes Care. 31:173–175. 2008.
|
|
10.
|
Brunton S: Insulin delivery systems:
reducing barriers to insulin therapy and advancing diabetes
mellitus treatment. Am J Med. 121(Suppl): S35–S41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Pickup J, Mattock M and Kerry S: Glycaemic
control with continuous subcutaneous insulin infusion compared with
intensive insulin injections in patients with type 1 diabetes:
meta-analysis of randomised controlled trials. BMJ. 324:7052002.
View Article : Google Scholar
|
|
12.
|
Pickup JC and Sutton AJ: Severe
hypoglycaemia and glycaemic control in Type 1 diabetes:
meta-analysis of multiple daily insulin injections compared with
continuous subcutaneous insulin infusion. Diabet Med. 25:765–774.
2008. View Article : Google Scholar
|
|
13.
|
Bode BW, Steed RD and Davidson PC:
Reduction in severe hypoglycemia with long-term continuous
subcutaneous insulin infusion in type I diabetes. Diabetes Care.
19:324–327. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Leiter LA; The Diabetes Control and
Complications Trial Research Group: Use of bioelectrical impedance
analysis measurements in patients with diabetes. Am J Clin Nutr.
64(Suppl): 515S–518S. 1996.PubMed/NCBI
|
|
15.
|
Herman WH, Ilag LL, Johnson SL, Martin CL,
Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB,
Halter JB and Raskin P: A clinical trial of continuous subcutaneous
insulin infusion versus multiple daily injections in older adults
with type 2 diabetes. Diabetes Care. 28:1568–1573. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Saudek CD, Duckworth WC, Giobbie-Hurder A,
Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA,
Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS and
Morgan NA; Department of Veterans Affairs Implantable Insulin Pump
Study Group: Implantable insulin pump vs multiple-dose insulin for
non-insulin-dependent diabetes mellitus: a randomized clinical
trial. JAMA. 276:1322–1327. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Valensi P, Moura I, Le Magoarou M, Pariès
J, Perret G and Attali JR: Short-term effects of continuous
subcutaneous insulin infusion treatment on insulin secretion in
non-insulin-dependent overweight patients with poor glycaemic
control despite maximal oral anti-diabetic treatment. Diabetes
Metab. 23:51–57. 1997.
|
|
18.
|
DeVries JH, Snoek FJ, Kostense PJ, Masurel
N and Heine RJ; Dutch Insulin Pump Study Group: A randomized trial
of continuous subcutaneous insulin infusion and intensive injection
therapy in type 1 diabetes for patients with long-standing poor
glycemic control. Diabetes Care. 25:2074–2080. 2002. View Article : Google Scholar
|
|
19.
|
Hanaire-Broutin H, Melki V,
Bessières-Lacombe S and Tauber JP; The Study Group for the
Development of Pump Therapy in Diabetes: Comparison of continuous
subcutaneous insulin infusion and multiple daily injection regimens
using insulin lispro in type 1 diabetic patients on intensified
treatment: a randomized study. Diabetes Care. 23:1232–1235. 2000.
View Article : Google Scholar
|
|
20.
|
Raskin P, Bode BW, Marks JB, Hirsch IB,
Weinstein RL, McGill JB, Peterson GE, Mudaliar SR and Reinhardt RR:
Continuous subcutaneous insulin infusion and multiple daily
injection therapy are equally effective in type 2 diabetes: a
randomized, parallel-group, 24-week study. Diabetes Care.
26:2598–2603. 2003. View Article : Google Scholar
|
|
21.
|
García-García E, Galera R, Aguilera P,
Cara G and Bonillo A: Long-term use of continuous subcutaneous
insulin infusion compared with multiple daily injections of
glargine in pediatric patients. J Pediatr Endocrinol Metab.
20:37–40. 2007.PubMed/NCBI
|
|
22.
|
Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ
and Qin GM: Inflammatory cytokines, adiponectin, insulin resistance
and metabolic control after periodontal intervention in patients
with type 2 diabetes and chronic periodontitis. Intern Med.
50:1569–1574. 2011. View Article : Google Scholar
|
|
23.
|
Gorden P, Hendricks CM and Roth J:
Circulating proinsulin-like component in man: increased proportion
in hypoinsulinemic states. Diabetologia. 10:469–474. 1974.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Larsen ML, Hørder M and Mogensen EF:
Effect of long-term monitoring of glycosylated hemoglobin levels in
insulin-dependent diabetes mellitus. N Engl J Med. 323:1021–1025.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Nathan DM, Buse JB, Davidson MB,
Ferrannini E, Holman RR, Sherwin R and Zinman B; American Diabetes
Association; European Association for Study of Diabetes: Medical
management of hyperglycemia in type 2 diabetes: a consensus
algorithm for the initiation and adjustment of therapy: a consensus
statement of the American Diabetes Association and the European
Association for the Study of Diabetes. Diabetes Care. 32:193–203.
2009. View Article : Google Scholar
|
|
26.
|
Ceriello A: Postprandial hyperglycemia and
diabetes complications: is it time to treat? Diabetes. 54:1–7.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Hirsch IB and Brownlee M: Should minimal
blood glucose variability become the gold standard of glycemic
control? J Diabetes Complications. 19:178–181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Cryer PE: The barrier of hypoglycemia in
diabetes. Diabetes. 57:3169–3176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Gerstein HC, Miller ME, Byington RP, Goff
DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F,
Grimm RH Jr, Probstfield JL, Simons-Morton DG and Friedewald WT:
Effects of intensive glucose lowering in type 2 diabetes. N Engl J
Med. 358:2545–2559. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Zammitt NN and Frier BM: Hypoglycemia in
type 2 diabetes: pathophysiology, frequency, and effects of
different treatment modalities. Diabetes Care. 28:2948–2961. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Zhang L, Gianani R, Nakayama M, Liu E,
Kobayashi M, Baschal E, Yu L, Babu S, Dawson A, Johnson K, Jahromi
M, Aly T, Fain P, Barker J, Rewers M and Eisenbarth GS: Type 1
diabetes: chronic progressive autoimmune disease. Novartis Found
Symp. 292:85–98. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Ligthelm R and Davidson J: Initiating
insulin in primary care - the role of modern premixed formulations.
Prim Care Diabetes. 2:9–16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Zinman B: Initial combination therapy for
type 2 diabetes mellitus: is it ready for prime time? Am J Med.
124(Suppl): S19–S34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ye RG and Lu ZY: Organophosphorus
intoxication. Department of Internal Medicine. 6th edition.
People’s Medical Publishing House; Beijing, China: pp. 961–967.
2003
|
